<DOC>
	<DOCNO>NCT00484237</DOCNO>
	<brief_summary>This study compare safety efficacy two regimen etanercept patient rheumatoid arthritis ( RA ) . The two regimen compare 25mg twice weekly regimen 50mg weekly regimen .</brief_summary>
	<brief_title>A Study Evaluating 10 mg 25 mg Doses Etanercept Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description>This study compare safety efficacy two regimen etanercept patient rheumatoid arthritis ( RA ) . The two regimen compare 25mg twice weekly regimen 50mg weekly regimen .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Presence &gt; 6 swollen joint &gt; 6 tender joint Inadequate response least one disease modify antirheumatic drug ( DMARD ) Have treat DMARD least 4 week prior baseline visit Previous treatment etanercept , antibody TNFα , TNFα inhibitor Received investigational drug within 6 month baseline visit Received intraarticular hyaluronic acid injection within 4 week baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>